Pay in 4 interest-free payments of $6.98 Learn more
Ships within 48 hours · Estimated delivery Nov 8 - Nov 13
157: 291 294 Leffell MS
Trials administering oral or intravenous arginine and citrulline have reported improvements in uteroplacental hemodynamics and gestational blood-pressure control, without documenting teratogenicity or major maternal complications
(2015) 213:S11522
Menopause Diet: Key Concepts and Nutritional Needs The hormonal upheaval during menopause, particularly the decline in estrogen, can increase the risk of osteoporosis, cardiovascular disease, and altered metabolic states
Retatrutide is an investigational triple receptor agonist developed by Eli Lilly that targets GLP-1, GIP, and glucagon receptors, giving it a broader metabolic mechanism than single- or dual-pathway therapies
